Chief Executive Officer
Mon, Nov 21, 2022
Nov 21
400 shares @ $21.38
Decreased holdings by 0.00%
Net across this filing: -1.00% (-12,500 shares)
32nd largest trade (out of 185)
Trade made by an officer
Net holdings across this filing: -1.0% (-12,500 shares)
44% win rate · -2.8% median edge vs SPY (9 trades, 90-day · small sample)
Price 28% above 200-day moving average
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology